Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("WALLIS, Carole L")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 22 of 22

  • Page / 1
Export

Selection :

  • and

Varied Patterns of HIV-1 Drug Resistance on Failing First-Line Antiretroviral Therapy in South AfricaWALLIS, Carole L; MELLORS, John W; VENTER, Willem D. F et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 53, Num 4, pp 480-484, issn 1525-4135, 5 p.Article

EMERGENCE OF DRUG RESISTANCE IN HIV-1 SUBTYPE C INFECTED CHILDREN FAILING THE SOUTH AFRICAN NATIONAL ANTIRETROVIRAL ROLL-OUT PROGRAMWALLIS, Carole L; ERASMUS, Linda; VARUGHESE, Sheba et al.The Pediatric infectious disease journal. 2009, Vol 28, Num 12, pp 1123-1125, issn 0891-3668, 3 p.Article

Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out StavudineTANG, Michele W; RHEE, Soo-Yon; RUXRUNGTHAM, Kiat et al.The Journal of infectious diseases. 2013, Vol 207, issn 0022-1899, S70-S77, SUP2Article

Frequent Emergence of N348I in HIV-1 Subtype C Reverse Transcriptase with Failure of Initial Therapy Reduces Susceptibility to Reverse-Transcriptase InhibitorsBREHM, Jessica H; KOONTZ, Dianna L; WALLIS, Carole L et al.Clinical infectious diseases. 2012, Vol 55, Num 5, pp 737-745, issn 1058-4838, 9 p.Article

Drug Susceptibility and Resistance Mutations After First-Line Failure in Resource Limited SettingsWALLIS, Carole L; AGA, Evgenia; RIBAUDO, Heather et al.Clinical infectious diseases. 2014, Vol 59, Num 5, pp 706-715, issn 1058-4838, 10 p.Article

Greater Suppression of Nevirapine Resistance With 21- vs 7-Day Antiretroviral Regimens After Intrapartum Single-Dose Nevirapine for Prevention of Mother-to-Child Transmission of HIVMCMAHON, Deborah K; LU ZHENG; WALLIS, Carole L et al.Clinical infectious diseases. 2013, Vol 56, Num 7, pp 1044-1051, issn 1058-4838, 8 p.Article

Accumulation of HIV Drug Resistance Mutations in Patients Failing First-Line Antiretroviral Treatment in South AfricaSIGALOFF, Kim C. E; RAMATSEBE, Tina; VIANA, Raquel et al.AIDS research and human retroviruses. 2012, Vol 28, Num 2, pp 171-175, issn 0889-2229, 5 p.Article

Genotype assays and third-line ART in resource-limited settings: a simulation and cost-effectiveness analysis of a planned clinical trialLORENZANA, Sarah B; HUGHES, Michael D; WALLIS, Carole L et al.AIDS (London). 2012, Vol 26, Num 9, pp 1085-1095, issn 0269-9370, 11 p.Article

Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan AfricaSIGALOFF, Kim C. E; HAMERS, Raph L; STEVENS, Wendy S et al.The Journal of infectious diseases. 2012, Vol 205, Num 11, pp 1739-1744, issn 0022-1899, 6 p.Article

Building Capacity for the Assessment of HIV Drug Resistance: Experiences From the PharmAccess African Studies to Evaluate Resistance NetworkHAMERS, Raph L; STRAATSMA, Elske; WELLINGTON, Maureen et al.Clinical infectious diseases. 2012, Vol 54, issn 1058-4838, S261-S265, SUP4Article

Natural Polymorphisms of integrase Among HIV Type 1-Infected South African PatientsFISH, Muhammad Q; HEWER, Raymond; WALLIS, Carole L et al.AIDS research and human retroviruses. 2010, Vol 26, Num 4, pp 489-493, issn 0889-2229, 5 p.Article

Development and evaluation of an assay for HIV-1 protease and reverse transcriptase drug resistance genotyping of all major group-M subtypesAITKEN, Susan C; KLIPHUIS, Aletta; WALLIS, Carole L et al.Journal of clinical virology. 2012, Vol 54, Num 1, pp 21-25, issn 1386-6532, 5 p.Article

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational studyHAMERS, Raph L; WALLIS, Carole L; NANKYA, Immaculate et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 750-759, issn 1473-3099, 10 p.Article

Transmitted HIV Type 1 Drug Resistance Among Individuals with Recent HIV Infection in East and Southern AfricaPRICE, Matt A; WALLIS, Carole L; KALEEBU, Pontiano et al.AIDS research and human retroviruses. 2011, Vol 27, Num 1, pp 5-12, issn 0889-2229, 8 p.Article

Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1WALLIS, Carole L; PAPATHANASOPOULOS, Maria A; RINKE DE WIT, Tobias F et al.Journal of virological methods. 2010, Vol 163, Num 2, pp 505-508, issn 0166-0934, 4 p.Article

E138A in HIV-1 reverse transcriptase is more common in subtype C than B: Implications for rilpivirine use in resource-limited settingsSLUIS-CREMER, Nicolas; JORDAN, Michael R; HUBER, Kelly et al.Antiviral research. 2014, Vol 107, pp 31-34, issn 0166-3542, 4 p.Article

Automated sequence analysis and editing software for HIV drug resistance testingSTRUCK, Daniel; WALLIS, Carole L; STEVENS, Wendy et al.Journal of clinical virology. 2012, Vol 54, Num 1, pp 30-35, issn 1386-6532, 6 p.Article

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort studyHAMERS, Raph L; SCHUURMAN, Rob; OSIBOGUN, Akin et al.Lancet. Infectious diseases (print). 2012, Vol 12, Num 4, pp 307-317, issn 1473-3099, 11 p.Article

Lopinavir/ritonavir monotherapy after virologic failure of first-line antiretroviral therapy in resource-limited settingsBARTLETT, John A; RIBAUDO, Heather J; SUPPARATPINYO, Khuanchai et al.AIDS (London). 2012, Vol 26, Num 11, pp 1345-1353, issn 0269-9370, 9 p.Article

Low rates of nucleoside reverse transcriptase inhibitor resistance in a well―monitored cohort in South Africa on antiretroviral therapyWALLIS, Carole L; PAPATHANASOPOLOUS, Maria A; STEVENS, Wendy et al.Antiviral therapy (London). 2012, Vol 17, Num 2, pp 313-320, issn 1359-6535, 8 p.Article

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART StrategiesHAMERS, Raph L; SIGALOFF, Kim C. E; OSIBOGUN, Akin et al.Clinical infectious diseases. 2012, Vol 54, Num 11, pp 1660-1669, issn 1058-4838, 10 p.Article

Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in AfricaSIGALOFF, Kim C. E; HAMERS, Raph L; STEVENS, Wendy S et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 1, pp 23-31, issn 1525-4135, 9 p.Article

  • Page / 1